Cargando…

Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability

Inherited bone marrow failure syndromes (IBMFS) are a complex and heterogeneous group of genetic diseases. To date, at least 13 IBMFS have been characterized. Their pathophysiology is associated with germline pathogenic variants in genes that affect hematopoiesis. A couple of these diseases also hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiesco-Roa, Moisés Ó., García-de Teresa, Benilde, Leal-Anaya, Paula, van ‘t Hek, Renée, Wegman-Ostrosky, Talia, Frías, Sara, Rodríguez, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453478/
https://www.ncbi.nlm.nih.gov/pubmed/36091172
http://dx.doi.org/10.3389/fonc.2022.949435
_version_ 1784785150894145536
author Fiesco-Roa, Moisés Ó.
García-de Teresa, Benilde
Leal-Anaya, Paula
van ‘t Hek, Renée
Wegman-Ostrosky, Talia
Frías, Sara
Rodríguez, Alfredo
author_facet Fiesco-Roa, Moisés Ó.
García-de Teresa, Benilde
Leal-Anaya, Paula
van ‘t Hek, Renée
Wegman-Ostrosky, Talia
Frías, Sara
Rodríguez, Alfredo
author_sort Fiesco-Roa, Moisés Ó.
collection PubMed
description Inherited bone marrow failure syndromes (IBMFS) are a complex and heterogeneous group of genetic diseases. To date, at least 13 IBMFS have been characterized. Their pathophysiology is associated with germline pathogenic variants in genes that affect hematopoiesis. A couple of these diseases also have genomic instability, Fanconi anemia due to DNA damage repair deficiency and dyskeratosis congenita/telomere biology disorders as a result of an alteration in telomere maintenance. Patients can have extramedullary manifestations, including cancer and functional or structural physical abnormalities. Furthermore, the phenotypic spectrum varies from cryptic features to patients with significantly evident manifestations. These diseases require a high index of suspicion and should be considered in any patient with abnormal hematopoiesis, even if extramedullary manifestations are not evident. This review describes the disrupted cellular processes that lead to the affected maintenance of the genome structure, contrasting the dysmorphological and oncological phenotypes of Fanconi anemia and dyskeratosis congenita/telomere biology disorders. Through a dysmorphological analysis, we describe the phenotypic features that allow to make the differential diagnosis and the early identification of patients, even before the onset of hematological or oncological manifestations. From the oncological perspective, we analyzed the spectrum and risks of cancers in patients and carriers.
format Online
Article
Text
id pubmed-9453478
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94534782022-09-09 Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability Fiesco-Roa, Moisés Ó. García-de Teresa, Benilde Leal-Anaya, Paula van ‘t Hek, Renée Wegman-Ostrosky, Talia Frías, Sara Rodríguez, Alfredo Front Oncol Oncology Inherited bone marrow failure syndromes (IBMFS) are a complex and heterogeneous group of genetic diseases. To date, at least 13 IBMFS have been characterized. Their pathophysiology is associated with germline pathogenic variants in genes that affect hematopoiesis. A couple of these diseases also have genomic instability, Fanconi anemia due to DNA damage repair deficiency and dyskeratosis congenita/telomere biology disorders as a result of an alteration in telomere maintenance. Patients can have extramedullary manifestations, including cancer and functional or structural physical abnormalities. Furthermore, the phenotypic spectrum varies from cryptic features to patients with significantly evident manifestations. These diseases require a high index of suspicion and should be considered in any patient with abnormal hematopoiesis, even if extramedullary manifestations are not evident. This review describes the disrupted cellular processes that lead to the affected maintenance of the genome structure, contrasting the dysmorphological and oncological phenotypes of Fanconi anemia and dyskeratosis congenita/telomere biology disorders. Through a dysmorphological analysis, we describe the phenotypic features that allow to make the differential diagnosis and the early identification of patients, even before the onset of hematological or oncological manifestations. From the oncological perspective, we analyzed the spectrum and risks of cancers in patients and carriers. Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9453478/ /pubmed/36091172 http://dx.doi.org/10.3389/fonc.2022.949435 Text en Copyright © 2022 Fiesco-Roa, García-de Teresa, Leal-Anaya, van ‘t Hek, Wegman-Ostrosky, Frías and Rodríguez https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Fiesco-Roa, Moisés Ó.
García-de Teresa, Benilde
Leal-Anaya, Paula
van ‘t Hek, Renée
Wegman-Ostrosky, Talia
Frías, Sara
Rodríguez, Alfredo
Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability
title Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability
title_full Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability
title_fullStr Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability
title_full_unstemmed Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability
title_short Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability
title_sort fanconi anemia and dyskeratosis congenita/telomere biology disorders: two inherited bone marrow failure syndromes with genomic instability
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453478/
https://www.ncbi.nlm.nih.gov/pubmed/36091172
http://dx.doi.org/10.3389/fonc.2022.949435
work_keys_str_mv AT fiescoroamoiseso fanconianemiaanddyskeratosiscongenitatelomerebiologydisorderstwoinheritedbonemarrowfailuresyndromeswithgenomicinstability
AT garciadeteresabenilde fanconianemiaanddyskeratosiscongenitatelomerebiologydisorderstwoinheritedbonemarrowfailuresyndromeswithgenomicinstability
AT lealanayapaula fanconianemiaanddyskeratosiscongenitatelomerebiologydisorderstwoinheritedbonemarrowfailuresyndromeswithgenomicinstability
AT vanthekrenee fanconianemiaanddyskeratosiscongenitatelomerebiologydisorderstwoinheritedbonemarrowfailuresyndromeswithgenomicinstability
AT wegmanostroskytalia fanconianemiaanddyskeratosiscongenitatelomerebiologydisorderstwoinheritedbonemarrowfailuresyndromeswithgenomicinstability
AT friassara fanconianemiaanddyskeratosiscongenitatelomerebiologydisorderstwoinheritedbonemarrowfailuresyndromeswithgenomicinstability
AT rodriguezalfredo fanconianemiaanddyskeratosiscongenitatelomerebiologydisorderstwoinheritedbonemarrowfailuresyndromeswithgenomicinstability